FOLD

Amicus Therapeutics
FOLD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.86B
EV
$2.05B
Shares Outstanding
307.93M
Beta
0.53

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$15.82
P/E 2025E
263.93x
P/Revenue 2025E
2.99x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amicus Therapeutics, Inc.

gainify
FOLD

Amicus Therapeutics, Inc.

FOLD

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed ...

Sector

Healthcare

Industry

Biotechnology

CEO

Campbell, Bradley

Employees

499

IPO Date

2007-05-31

Headquarters

47 Hulfish Street, Princeton, New Jersey, 08542, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.